Reported Reactions

Devices › Accessories, soft lens products

Device brand name · Lens care disinfecting solutions

Opti-Free Replenish: medical device reports filed with FDA

324 reports name it, 2007–2015. Manufacturer given most often on reports: Alcon - Fort Worth / Alcon Laboratories. Product code LPN.

324
device reports naming the brand
0% of all MAUDE reports · about 17 a year
0
reports, 12 months to August 2026
0 in the 12 months before
0%
classified as malfunction
40.3% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 324 reports that name the brand "Opti-Free Replenish" (lens care disinfecting solutions), received between May 2007 and March 2015; the manufacturer given most often on reports is Alcon - Fort Worth / Alcon Laboratories. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.7%) and other (0.3%); across all accessories, soft lens products reports (product code LPN) death is recorded in 0% and malfunction in 40.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are insufficient device problem information (30.6%), material discolored (4.3%) and device operates differently than expected (1.2%). The patient problems coded most often are red eye(s), corneal infiltrates and keratitis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Opti-Free Replenish was received in the five years to August 2026; the latest was received in March 2015.

By year received

0541072007: 1120072008: 1620082009: 1320092010: 10720102011: 7720112012: 8420122013: 520132014: 720142015: 42015

Event type and report source

Event type, as classified on the report

Death0%0
Injury99.7%323
Malfunction0%0
Other0.3%1
Not given0%0

Who filed the report

Manufacturer report91.4%296
Voluntary report8.6%28
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 8,035 reports carrying product code LPN. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Insufficient device problem information9930.6%4.7%
Material discolored144.3%0.4%
Device operates differently than expectedthe device behaved unexpectedly41.2%1.2%
Contamination30.9%1.7%
Microbial contamination of device30.9%0.3%
Breakthe device broke20.6%0.4%
Device emits odor20.6%0.5%
Device expiration issue20.6%0.4%
Patient-device incompatibilitythe device did not suit the patient20.6%0.9%
Detachment of device component10.3%0%
Device damaged by another device10.3%0.1%
Improper or incorrect procedure or method10.3%2.4%
Replace10.3%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Red eye(s)11736.1%
Corneal infiltrates8225.3%
Keratitis7222.2%
Painpain, site not specified4915.1%
Burning sensationa burning feeling4513.9%
Visual impairmentreduced vision4413.6%
Irritationirritation4112.7%
Corneal ulcer3711.4%
Blurred vision3410.5%
Conjunctivitispink eye247.4%
Itching sensation226.8%
Excessive tear production185.6%
Swellingswelling175.2%
Discomfortdiscomfort164.9%
Discharge154.6%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOpti-Free ReplenishProduct code LPNAll MAUDE reports
Reports3248,03526,136,888
Share of that pool—4%0%
Classified as death, per 1,000 reports009
Classified as injury99.7%50.7%36.2%
Classified as malfunction0%40.3%62.3%
Filed by the manufacturer91.4%69.5%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LPN

BrandReportsLatest 12 monthsClassified as death
Peroxiclear Hydrogen Peroxide Solution2,84500%
Renu With Moistureloc Multi-Purpose Solution38700%
Clear Care26400%
Renu With Moisture Loc20100%
Complete Moisture Plus18800%
Amo Complete Moisture Plus17400%
Renu Multiplus Multi-Purpose Solution16100%
Allergan Cup17400%
Acuvue Oasys719270%
ISPAN Perfluoropropane (C3F8 gas)215350%
Alcon18020%
Focus Night & Day21500%
Totalcare6,66100%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Opti-Free Replenish reports

How many FDA reports name Opti-Free Replenish?

324 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (99.7%) and other (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

insufficient device problem information (30.6%), material discolored (4.3%), device operates differently than expected (1.2%), contamination (0.9%) and microbial contamination of device (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (91.4%) and voluntary reports (8.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Opti-Free Replenish was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.